BI 1002494, a Novel Potent and Selective Oral Spleen Tyrosine Kinase Inhibitor, Displays Differential Potency in Human Basophils and B Cells
Lamb, David J, Wollin, Stefan Lutz, Schnapp, Andreas, Bischoff, Daniel, Erb, Klaus J, Bouyssou, Thierry, Guilliard, Bernd, Strasser, Christine, Wex, Eva, Blum, Sylvia, Thaler, Eva, Nickel, Helga, Radmacher, Oliver, Haas, Hannah, Swantek, Jennifer L, Souza, Don, Canfield, Melissa, White, Della, Panzenbeck, Mark, Kashem, Mohammed A, Sanville-Ross, Mary, Kono, Takeshi, Sewald, Katherina, Braun, Armin, Obernolte, Helena, Danov, Olga, Schaenzle, Gerhard, Rast, Georg, Maier, Gerd-Michael, Hoffmann, Matthias
Published in The Journal of pharmacology and experimental therapeutics (01.06.2016)
Published in The Journal of pharmacology and experimental therapeutics (01.06.2016)
Get full text
Journal Article